logo
Select company
Select metric
$ 18.7MNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
16
Sector
27
Industry
-
History
58
$ 14.09Close
$ 3.99 - $ 37.45 52-Week Range
Ticker Information

Ticker

SCLX

Company Name

SCILEX HOLDING CO

Sector

Healthcare

Industry

Drug Manufacturers - General

Exchange

NASDAQ

SCILEX HOLDING CO - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SCLX - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ 18.7M
3/31/2025$ 31.48M
12/31/2024$ 42.08M
9/30/2024$ 30.83M
6/30/2024$ 30.4M
3/31/2024$ 33.15M
12/31/2023$ 24.61M
9/30/2023$ 16.7M
6/30/2023$ 16.91M
12/31/2022$ 96K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SCILEX HOLDING CO's latest trailing twelve months (TTM) CF - Equity stands at $ 25K.
  • Over the past 5 years, SCILEX HOLDING CO's average CF - Equity has been $ 18.85M.
  • The median CF - Equity for SCILEX HOLDING CO during this period was $ 24.61M
  • SCILEX HOLDING CO reached its highest CF - Equity over the past 5 years at $ 135.6M.
  • The lowest CF - Equity recorded by SCILEX HOLDING CO in the same timeframe $ -135.5M

SCILEX HOLDING CO's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
SPRO : SPERO THERAPEUTICS INC $ 0KRMD : KORU MEDICAL SYSTEMS INC $ 0CELU : CELULARITY INC $ 3.53MLNSR : LENSAR INC $ -137KUTMD : UTAH MEDICAL PRODUCTS INC $ -17.28MIVVD : INVIVYD INC $ 518KTHTX : THERATECHNOLOGIES INC -TLSI : TRISALUS LIFE SCIENCES INC $ 29.86MCVRX : CVRX INC $ 44.2MCCCC : C4 THERAPEUTICS INC $ 10.16M

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

SCLX - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ -135.5M

Minimum

Jun 30, 2022

$ 135.6M

Maximum

Dec 31, 2021

$ 18.85M

Average

$ 24.61M

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 139.46K with a standard deviation of $ 17.67M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.9K
min$ -60.59M
max$ 60.64M
average$ 139.46K
median$ 0
std$ 17.67M